CAS: 6970-19-0; 3,4,5-Triethoxybenzoic Acid

上下游产品

CAS号39666-77-8 methyl 3,4,5-tr... | CAS号99-24-1 没食子酸甲酯 | CAS号64-67-5 硫酸二乙酯 | CAS号149-91-7 没食子酸; 3,4,5-三羟基苯甲酸 | CAS号861320-32-3 3,5,7-triethoxy... | CAS号31374-71-7 Benzoic acid,3,... | CAS号90109-63-0 2-(3,4,5-trieth... | CAS号90132-55-1 2,6-diethoxyphenol | CAS号61470-52-8 3,5-diethoxy-4-... | CAS号379254-36-1 3,4,5-三乙氧基苯并肼 | CAS号39727-75-8 3,4,5-三乙氧基苄醇

没食子酸甲酯置于potassium Carbonate,Potassium Hydroxide体系中,用 水,N,N-二甲基甲酰胺,异丙醇 作为反应溶剂,化学反应生成 3,4,5-三乙氧基苯甲酸
参考文献:扩展 2-苯基苯并碲唑库:乙氧基官能团对紫外/可见光吸收特性的红移效应
标题:扩展 2-苯基苯并碲唑库:乙氧基官能团对紫外/可见光吸收特性的红移效应
摘要:这项工作描述了在 2 位带有苯环的新型苯并碲唑系列的高产率合成,该苯环被不同的乙氧基链官能化.改变这些官能团的数量和位置决定了固态自组装的差异,以及目标分子的光物理特性.正如对每个分子的 Homo-Lumo 间隙的理论计算所预期的那样,与未取代的苯并碲唑相比,邻位和对位乙氧基链的存在决定了吸收峰中高达 20 Nm 的红移.同样,对于那些带有o的衍生物,在125 Te NMR 光谱的化学位移中观测到更显着的变化.-和对-乙氧基官能化.
DOI:10.1055/s-0041-1737898

专利信息

专利号:US-6664282-B2
优先权日:1999-09-17
标 题:Synthesis of [3,5,7]-1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds
发明人：ELABDELLAOUI HASSAN M; OSTRESH JOHN M; HOUGHTEN RICHARD A
权利人:TORREY PINES INST
摘要:Individual substituted [3,5,7]-1H-imidazo[1,5-a]imidazol-2(3H)-one compounds and their pharmaceutically-acceptable salts are disclosed, as are libraries of such compounds. Methods of preparing and using the libraries of compounds as well as individual compounds of the libraries are also disclosed.

专利号:US-5856107-A
优先权日:1997-02-04
标 题 :Combinatorial libraries of imidazol-pyrido-indole and imidazol-pyrido-benzothiophene derivatives, methods of making the libraries and compounds therein
发明人：OSTRESH JOHN M; HOUGHTEN RICHARD A
权利人:TREGA BIOSCIENCES INC
摘要:The invention provides a rapid approach for combinatorial synthesis and screening of libraries of imidazol-pyrido-indole and imidazol-pyrido-benzothiophene compounds. The present invention further provides methods of preparing the libraries and the individual compounds made by the combinatorial synthesis.

专利号:US-12180188-B2
优先权日:2020-05-19
标题:Antifibrotic compounds and related methods
发明人：STEFANOVIC BRANKO; NEFZI ADEL
权利人:UNIV FLORIDA STATE RES FOUND; THE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES
摘要:This discloses that compounds of Formula 1 have antifibrotic properties. In particular, this discloses a pharmaceutical composition including one or more compounds of Formula 1 and methods of using compounds of Formula 1 in fibrosis treatment and inhibiting type 1 collagen synthesis.

专利号:EP-1218337-A1
优先权日:1999-09-17
标题 :Synthesis of 3,5,7]-1h-imidazo 1,5-a]imidazol-2(3h)-one compounds

专利号:US-6545032-B1
优先权日:1999-09-17
标题:Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds

专利号:US-2002193608-A1
优先权日:1999-09-17
标题 :Synthesis of [3,5,7]--1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds